echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > For chronic cough!

    For chronic cough!

    • Last Update: 2022-05-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the official website of CDE showed that Hengrui Medicine’s clinical trial application for HRS-2261 tablets was approved for the treatment of chronic cough


    Chronic cough lasting ≥8 weeks, no evidence of lung disease on chest X-ray, and cough as the main or only symptom


    At present, Hengrui's product pipeline is very rich, and it has carried out forward-looking layout in many fields such as oncology, autoimmune diseases, pain management, ophthalmology, cardiovascular diseases, metabolic diseases, infectious diseases, and respiratory diseases


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.